Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProvayBlue in acquired methemoglobinemia
NCT03395223Phase 4Completed
- Sponsor
- Provepharma
- Start
- Jul 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylene blue in acquired methemoglobinemia, sponsored by Provepharma. Started Jul 2018; status: completed.
02
Drugs
methylene blue
03
Conditions
acquired methemoglobinemia
Beyond the preview
Go deeper on NCT03395223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03395223.